Author:
Klinghammer K.,Gauler T.,Dietz A.,Grünwald V.,Stöhlmacher J.,Knipping S.,Schroeder M.,Guntinas-Lichius O.,Frickhofen N.,Lindeman H.-W.,Fietkau R.,Haxel B.,Große-Thie C.,Maschmeyer G.,Zipfel M.,Martus P.,Knoedler M.,Keilholz U.
Reference13 articles.
1. Platinum-based chemotherapy plus cetuximab in head and neck cancer;Vermorken;N Engl J Med,2008
2. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer;Vermorken;N Engl J Med,2007
3. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer;Posner;N Engl J Med,2007
4. Therapeutic synergy of oral taxane BMS-275183 and cetuximab versus human tumor xenografts;Rose;Clin Cancer Res,2004
5. Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer;Argiris;J Clin Oncol,2010
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献